Thomas Kull

3.1k total citations
67 papers, 2.3k citations indexed

About

Thomas Kull is a scholar working on Management Information Systems, Strategy and Management and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Kull has authored 67 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Management Information Systems, 21 papers in Strategy and Management and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Kull's work include Quality and Supply Management (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Outsourcing and Supply Chain Management (11 papers). Thomas Kull is often cited by papers focused on Quality and Supply Management (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Outsourcing and Supply Chain Management (11 papers). Thomas Kull collaborates with scholars based in United States, Germany and Switzerland. Thomas Kull's co-authors include Srinivas Talluri, John G. Wacker, Scott C. Ellis, René Peters, Tingting Yan, Ram Narasimhan, Gerhard Glatting, David J. Closs, John W. Henke and Sven N. Reske and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Clinical Cancer Research.

In The Last Decade

Thomas Kull

65 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kull United States 26 1.2k 1000 254 232 224 67 2.3k
François Bergeron Canada 28 894 0.8× 1.2k 1.2× 19 0.1× 192 0.8× 120 0.5× 70 3.1k
Alexander Hübner Germany 34 314 0.3× 584 0.6× 288 1.1× 99 0.4× 1.3k 5.8× 81 3.4k
Vijay Sethi United States 27 462 0.4× 1.2k 1.2× 24 0.1× 152 0.7× 99 0.4× 80 3.3k
John Coyle United States 15 342 0.3× 467 0.5× 26 0.1× 128 0.6× 83 0.4× 40 1.5k
Carsten Zimmermann United States 10 313 0.3× 223 0.2× 214 0.8× 85 0.4× 70 0.3× 18 1.1k
Hongming Xie China 16 431 0.4× 224 0.2× 20 0.1× 38 0.2× 115 0.5× 56 819
Carmen López United Kingdom 19 462 0.4× 185 0.2× 57 0.2× 33 0.1× 353 1.6× 49 2.0k
Tai Young Kim South Korea 32 724 0.6× 85 0.1× 62 0.2× 112 0.5× 137 0.6× 82 3.7k
Marc Estève United Kingdom 25 196 0.2× 149 0.1× 72 0.3× 88 0.4× 34 0.2× 85 1.9k

Countries citing papers authored by Thomas Kull

Since Specialization
Citations

This map shows the geographic impact of Thomas Kull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kull more than expected).

Fields of papers citing papers by Thomas Kull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kull. The network helps show where Thomas Kull may publish in the future.

Co-authorship network of co-authors of Thomas Kull

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kull. A scholar is included among the top collaborators of Thomas Kull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kull. Thomas Kull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Tingting, et al.. (2024). When Complexity Meets Complexity: COVID‐19‐Induced Supply Chain Disruptions and Strategy Portfolio Efficiency. Journal of Operations Management. 71(1). 109–129. 5 indexed citations
2.
Ferreira, David, Thomas Kull, Andrew Hill, et al.. (2024). Enhancing guidewire efficacy for transradial access: the EAGER randomised controlled trial. European Heart Journal. 45(Supplement_1). 1 indexed citations
3.
Kull, Thomas, et al.. (2022). Planung und Organisation einer Radiojod- oder Lutetium-Therapie bei dialysepflichtigen Patienten. Nuklearmedizin - NuclearMedicine. 61(2). 205–206. 1 indexed citations
4.
Kull, Thomas, Josip Kotlar, & Martin Spring. (2017). Small and Medium Enterprise Research in Supply Chain Management: The Case for Single‐Respondent Research Designs. Journal of Supply Chain Management. 54(1). 23–34. 92 indexed citations
5.
Graeter, Tilmann, Wolfgang Kratzer, Suemeyra Oeztuerk, et al.. (2016). Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World Journal of Gastroenterology. 22(13). 3621–3621. 61 indexed citations
6.
Schiele, Holger, Scott C. Ellis, Michael Eßig, John W. Henke, & Thomas Kull. (2015). Managing Supplier Satisfaction: Social Capital and Resource Dependence Frameworks. Australasian Marketing Journal (AMJ). 23(2). 132–138. 44 indexed citations
7.
Kletting, Peter, Thomas Kull, Christian Maaß, et al.. (2015). Optimized Peptide Amount and Activity for 90Y-Labeled DOTATATE Therapy. Journal of Nuclear Medicine. 57(4). 503–508. 47 indexed citations
8.
Kletting, Peter, Thomas Kull, Donald Bunjes, et al.. (2011). Optimal preloading in radioimmunotherapy with anti-CD45 antibody. Medical Physics. 38(5). 2572–2578. 16 indexed citations
9.
Morgenroth, Agnieszka, Elizaveta A. Urusova, Thomas Kull, et al.. (2011). New Molecular Markers for Prostate Tumor Imaging: A Study on 2‐Methylene Substituted Fatty Acids as New AMACR Inhibitors. Chemistry - A European Journal. 17(36). 10144–10150. 20 indexed citations
10.
Kull, Thomas, José Cabrera, & René Peters. (2010). Catalytic Asymmetric Synthesis of trans‐Configured β‐Lactones: Cooperation of Lewis Acid and Ion Pair Catalysis. Chemistry - A European Journal. 16(30). 9132–9139. 55 indexed citations
11.
Kletting, Peter, Thomas Kull, Donald Bunjes, et al.. (2010). Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model. Journal of Nuclear Medicine. 51(3). 484–491. 42 indexed citations
12.
Kletting, Peter, Thomas Kull, Sven N. Reske, & Gerhard Glatting. (2009). Comparing time activity curves using the Akaike information criterion. Physics in Medicine and Biology. 54(21). N501–N507. 25 indexed citations
13.
Kull, Thomas & John G. Wacker. (2009). Quality management effectiveness in Asia: The influence of culture. Journal of Operations Management. 28(3). 223–239. 181 indexed citations
14.
Zlatopolskiy, Boris D., Agnieszka Morgenroth, Elizaveta A. Urusova, et al.. (2009). Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analogues. Bioorganic & Medicinal Chemistry Letters. 19(17). 5151–5154. 1 indexed citations
15.
Zlatopolskiy, Boris D., et al.. (2009). Synthesis and Biologic Study of IV-14, a New Ribonucleoside Radiotracer for Tumor Visualization. Journal of Nuclear Medicine. 50(11). 1895–1903. 9 indexed citations
16.
Kull, Thomas & René Peters. (2008). Contact Ion Pair Directed Lewis Acid Catalysis: Asymmetric Synthesis of trans‐Configured β‐Lactones. Angewandte Chemie International Edition. 47(29). 5461–5464. 58 indexed citations
17.
Buck, Andreas K., Martin Bommer, Malik E. Juweid, et al.. (2008). First Demonstration of Leukemia Imaging with the Proliferation Marker 18F-Fluorodeoxythymidine. Journal of Nuclear Medicine. 49(11). 1756–1762. 50 indexed citations
18.
Zsidisin, George A., Michael E. Smith, Regina C. McNally, & Thomas Kull. (2006). Evaluation criteria development and assessment of purchasing and supply management journals. Journal of Operations Management. 25(1). 165–183. 56 indexed citations
19.
Kull, Thomas, et al.. (2004). Quantitative Imaging of Yttrium-86 PET with the ECAT EXACT HR<SUP>+</SUP> in 2D Mode. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 482–490. 4 indexed citations
20.
Kull, Thomas, et al.. (2004). Quantitative Imaging Of Yttrium-86 Pet with the Ecat Exact Hr + In 2D Mode. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 482–490. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Bergeron Breakdown of academic impact, for papers by Alexander Hübner Breakdown of academic impact, for papers by Vijay Sethi Breakdown of academic impact, for papers by John Coyle Breakdown of academic impact, for papers by Carsten Zimmermann Breakdown of academic impact, for papers by Hongming Xie Breakdown of academic impact, for papers by Carmen López Breakdown of academic impact, for papers by Tai Young Kim Breakdown of academic impact, for papers by Marc Estève
Rankless by CCL
2026